JP2014511366A5 - - Google Patents

Download PDF

Info

Publication number
JP2014511366A5
JP2014511366A5 JP2013551335A JP2013551335A JP2014511366A5 JP 2014511366 A5 JP2014511366 A5 JP 2014511366A5 JP 2013551335 A JP2013551335 A JP 2013551335A JP 2013551335 A JP2013551335 A JP 2013551335A JP 2014511366 A5 JP2014511366 A5 JP 2014511366A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
pharmaceutical composition
independently selected
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013551335A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014511366A (ja
JP6010548B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/022724 external-priority patent/WO2012103336A1/en
Publication of JP2014511366A publication Critical patent/JP2014511366A/ja
Publication of JP2014511366A5 publication Critical patent/JP2014511366A5/ja
Application granted granted Critical
Publication of JP6010548B2 publication Critical patent/JP6010548B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013551335A 2011-01-26 2012-01-26 小分子RNase阻害剤および使用方法 Expired - Fee Related JP6010548B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161436342P 2011-01-26 2011-01-26
US61/436,342 2011-01-26
PCT/US2012/022724 WO2012103336A1 (en) 2011-01-26 2012-01-26 Small molecule rnase inhibitors and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016150928A Division JP6248151B2 (ja) 2011-01-26 2016-08-01 小分子RNase阻害剤および使用方法

Publications (3)

Publication Number Publication Date
JP2014511366A JP2014511366A (ja) 2014-05-15
JP2014511366A5 true JP2014511366A5 (OSRAM) 2015-03-05
JP6010548B2 JP6010548B2 (ja) 2016-10-19

Family

ID=46581163

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013551335A Expired - Fee Related JP6010548B2 (ja) 2011-01-26 2012-01-26 小分子RNase阻害剤および使用方法
JP2013551321A Pending JP2014510717A (ja) 2011-01-26 2012-01-26 小分子RNase阻害剤および使用方法
JP2016150928A Expired - Fee Related JP6248151B2 (ja) 2011-01-26 2016-08-01 小分子RNase阻害剤および使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013551321A Pending JP2014510717A (ja) 2011-01-26 2012-01-26 小分子RNase阻害剤および使用方法
JP2016150928A Expired - Fee Related JP6248151B2 (ja) 2011-01-26 2016-08-01 小分子RNase阻害剤および使用方法

Country Status (7)

Country Link
US (4) US9089545B2 (OSRAM)
EP (3) EP2667872B1 (OSRAM)
JP (3) JP6010548B2 (OSRAM)
CN (2) CN103635193B (OSRAM)
AU (2) AU2012211299B2 (OSRAM)
CA (2) CA2825907C (OSRAM)
WO (2) WO2012103295A2 (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6010548B2 (ja) 2011-01-26 2016-10-19 ユニバーシティー オブ ロチェスター 小分子RNase阻害剤および使用方法
SG11201700777VA (en) 2014-08-04 2017-02-27 Nuevolution As Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
EP3212183B1 (en) * 2014-10-31 2019-10-02 University of Rochester Synergistic compositions for treating microbial infections
US10351890B2 (en) 2014-12-09 2019-07-16 Medicosbiotech, Inc. Method for preparing recombinant proteins through reduction of rnpA gene expression
WO2016093606A1 (ko) * 2014-12-09 2016-06-16 한국과학기술원 rnpA 유전자 발현감소를 통한 재조합단백질의 제조방법
AU2018352695A1 (en) 2017-10-19 2020-05-28 Effector Therapeutics, Inc. Benzimidazole-indole inhibitors of Mnk1 and Mnk2
EP4076657A1 (en) 2019-12-20 2022-10-26 Nuevolution A/S Compounds active towards nuclear receptors
EP4076661A1 (en) 2019-12-20 2022-10-26 Nuevolution A/S Compounds active towards nuclear receptors
WO2021198955A1 (en) 2020-03-31 2021-10-07 Nuevolution A/S Compounds active towards nuclear receptors
EP4126875A1 (en) 2020-03-31 2023-02-08 Nuevolution A/S Compounds active towards nuclear receptors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD264918A1 (de) * 1987-11-26 1989-02-15 Paedagogische Hochschule Lisel Verfahren zur herstellung von 1,4-diacyl-thiosemicarbaziden
JPH03182742A (ja) * 1989-12-12 1991-08-08 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
CA2335389A1 (en) 2000-03-01 2001-09-01 Message Pharmaceuticals, Inc. Novel bacterial rnase p proteins and their use in identifying antibacterial compounds
US20020123077A1 (en) * 2000-09-29 2002-09-05 O'toole George A. Novel compounds capable of modulating biofilms
US20020052396A1 (en) * 2001-04-23 2002-05-02 Bailey Thomas R. Compounds, compositions and methods for treating or preventing viral infections and associated diseases
US7001924B2 (en) * 2001-09-21 2006-02-21 Message Pharmaceuticals Inhibitors of RNase P proteins as antibacterial compounds
US20050042674A9 (en) 2002-02-21 2005-02-24 Lin Yu Common ligand mimics: thiazolidinediones and rhodanines
US20040180889A1 (en) * 2002-03-01 2004-09-16 Pintex Pharmaceuticals, Inc. Pin1-modulating compounds and methods of use thereof
GB2386892A (en) * 2002-03-28 2003-10-01 Pantherix Ltd Carboxy containing (phenyl-/heterocyclyl-)methylene substituted azole & azine derivatives and their therapeutic use as antibacterials
US20040176277A1 (en) * 2003-03-03 2004-09-09 Pintex Pharmaceuticals, Inc. Methods of treating Pin1 associated disorders
FR2858324A1 (fr) * 2003-07-30 2005-02-04 Centre Nat Rech Scient Nouveaux composes antibiotiques, compositions pharmaceutiques les contenant et leurs utilisations
US20050187409A1 (en) * 2003-10-21 2005-08-25 Powers Gordon D. Inhibitors of RNase P proteins as antibacterial compounds
US7718680B2 (en) * 2004-09-23 2010-05-18 Burnham Institute For Medical Research Inhibition of lethal factor protease activity from anthrax toxin
BRPI0616137A2 (pt) 2005-09-22 2011-06-07 Meiji Seika Kaisha inibidor da metalo-ß-lactamase, composição farmacêutica, processo para tratar infecções bacterianas, composto, e, uso do mesmo
CA2709784A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
CN103983627A (zh) 2008-06-17 2014-08-13 韩国巴斯德研究所 作为抗结核病药的吡啶并嘧啶化合物
JP6010548B2 (ja) 2011-01-26 2016-10-19 ユニバーシティー オブ ロチェスター 小分子RNase阻害剤および使用方法

Similar Documents

Publication Publication Date Title
JP2014511366A5 (OSRAM)
JP2012144574A5 (OSRAM)
JP2013537203A5 (OSRAM)
JP2013541514A5 (OSRAM)
WO2009135179A3 (en) The use of solid carrier particles to improve the processability of a pharmaceutical agent
IN2014KN00948A (OSRAM)
PH12014500475A1 (en) Agricultural and horticultural fungicidal composition
AU2011274192A8 (en) Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof
JP2013056919A5 (OSRAM)
EA201391486A1 (ru) Способы и композиции для лечения болезни паркинсона
JP2014500861A5 (OSRAM)
JP2013533253A5 (OSRAM)
JP2014505107A5 (OSRAM)
HRP20140501T1 (hr) Derivati benzazepina korisni kao antagonisti vazopresina
JP2013514980A5 (OSRAM)
JP2011527299A5 (OSRAM)
JP2013510178A5 (OSRAM)
JP2015504091A5 (OSRAM)
BRPI0906444A8 (pt) compostos de 4-piridinona e seu uso para câncer
JP2012512863A5 (OSRAM)
JP2017517547A5 (OSRAM)
WO2014172188A3 (en) 4-pyridone derivative compounds and uses thereof as hiv integrase inhibitors
WO2013106761A3 (en) Antimicrobial agents
JP2013537240A5 (OSRAM)
JP2012511558A5 (OSRAM)